- Home
- BCLI vs MNDR Comparison
BCLI vs MNDR Comparison
Compare BCLI & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- MNDR
- Stock Information
- Founded
- BCLI 2000
- MNDR 2016
- Country
- BCLI United States
- MNDR Singapore
- Employees
- BCLI N/A
- MNDR N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- MNDR
- Sector
- BCLI Health Care
- MNDR
- Exchange
- BCLI Nasdaq
- MNDR Nasdaq
- Market Cap
- BCLI 9.1M
- MNDR 10.1M
- IPO Year
- BCLI N/A
- MNDR 2024
- Fundamental
- Price
- BCLI $2.25
- MNDR $0.30
- Analyst Decision
- BCLI Strong Buy
- MNDR
- Analyst Count
- BCLI 1
- MNDR 0
- Target Price
- BCLI $30.00
- MNDR N/A
- AVG Volume (30 Days)
- BCLI 112.8K
- MNDR 478.1K
- Earning Date
- BCLI 11-14-2024
- MNDR 02-16-2025
- Dividend Yield
- BCLI N/A
- MNDR N/A
- EPS Growth
- BCLI N/A
- MNDR N/A
- EPS
- BCLI N/A
- MNDR N/A
- Revenue
- BCLI N/A
- MNDR $13,968,535.00
- Revenue This Year
- BCLI N/A
- MNDR $188,831.77
- Revenue Next Year
- BCLI N/A
- MNDR $76.44
- P/E Ratio
- BCLI N/A
- MNDR N/A
- Revenue Growth
- BCLI N/A
- MNDR 77.38
- 52 Week Low
- BCLI $1.05
- MNDR $0.23
- 52 Week High
- BCLI $11.85
- MNDR $29.50
- Technical
- Relative Strength Index (RSI)
- BCLI 70.03
- MNDR N/A
- Support Level
- BCLI $1.45
- MNDR N/A
- Resistance Level
- BCLI $1.72
- MNDR N/A
- Average True Range (ATR)
- BCLI 0.18
- MNDR 0.00
- MACD
- BCLI 0.08
- MNDR 0.00
- Stochastic Oscillator
- BCLI 84.69
- MNDR 0.00
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.